Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
Abstract The prognosis of the coronavirus disease 2019 (COVID-19) patients is variable and depends on several factors. Current data about the impact of chronic obstructive pulmonary disease (COPD) and smoking on the clinical course of COVID-19 are still controversial. This study evaluated the preval...
Guardado en:
Autores principales: | Donato Lacedonia, Giulia Scioscia, Carla Santomasi, Paolo Fuso, Giovanna Elisiana Carpagnano, Andrea Portacci, Franco Mastroianni, Giovanni Larizza, Eugenio Sabato, Emanuela Profilo, Emanuela Resta, Maria Pia Foschino Barbaro, Onofrio Resta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/214bc99f4fef4e3e8e845549b9efef60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Giovanna Elisiana Carpagnano, et al.
Publicado: (2021) -
Thyroid Gland Disease as a Comorbid Condition in COPD
por: Aziz Gumus, et al.
Publicado: (2021) -
Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
por: Athanasios Voulgaris, et al.
Publicado: (2021) -
Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis.
por: Isaac K Sundar, et al.
Publicado: (2014) -
Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
por: Patrick F. Asare, et al.
Publicado: (2021)